Beyond Allocations: What Tanzania’s 2026/27 Budget Reveals About Fiscal Space for Health

Beyond commitment, this allocation reflects the difficult trade-offs the government has made in a case where fiscal space is structurally constrained by debt service obligations, a narrow revenue base, and an aid environment that is withdrawing faster than domestic alternatives can scale. As Tanzania implements UHI and prepares for declining donor support, the central question is whether domestic financing can grow quickly enough to sustain these reforms within an increasingly pressured fiscal environment.

A Growing Budget, a Constrained Fiscal Environment

The overall budget for 2026/27 stands at TZS 62.3 trillion (USD 23.7 billion), a 10.3% increase from the TZS 56.5 trillion (USD 21.5 billion) approved in 2025/26.

Domestic tax revenue is projected at TZS 29.8 trillion (USD 11.4 billion) — approximately 47.8% of the total budget — reflecting a tax-to-GDP ratio of 13.7%, below the threshold at which most low-income countries can adequately finance public services. Including non-tax revenues, total domestic resources reach approximately TZS 33.9 trillion (USD 12.9 billion), or 54.4% of the budget. External loans and concessional borrowing account for TZS 22.9 trillion (USD 8.7 billion), while grants from development partners contribute just TZS 0.56 trillion (USD 213.3 million) — a share that has fallen to 0.9% of the total budget as ODA declines structurally. Borrowed funds constitute approximately 38% of the financing envelope.

Debt service compounds this further. Interest and principal payments in 2025/26 totalled TZS 14.21 trillion (USD 5.4 billion) — roughly 25% of that year’s total budget. Total government debt stands at TZS 114.34 trillion (USD 43.6 billion), at 39.6% of GDP and technically within sustainability thresholds, but on a trajectory that could constrain future flexibility. The development spending that remains after recurrent obligations must accommodate the Standard Gauge Railway, energy infrastructure, roads, and ports — commitments that entail multi-year contractual obligations not easily renegotiated within annual budget cycles.

In summary, Tanzania’s fiscal environment is characterised by a revenue base that grows more slowly than its development ambitions, debt service absorbing a quarter of the total budget, and an aid environment that has become structurally unpredictable. These are the conditions within which every health financing decision is made.

Is Health Gaining Priority?

Understanding Tanzania’s health allocation requires distinguishing between two figures that are often conflated. The Ministry of Health government vote — the domestically financed allocation to the Ministry itself — stands at TZS 406.3 billion (USD 154.8 million) for 2026/27, against TZS 405.9 billion (USD 154.6 million) in 2025/26. That is a nominal increase of less than 0.1% — a real-terms decline when inflation is accounted for. The total health sector envelope, which includes TZS 358.6 billion (USD 136.6 million) in external development financing, reaches TZS 1.8 trillion (USD 685.7 million). Both figures are meaningful, but it is the government vote that reflects domestic fiscal commitment, and that figure has effectively stagnated.

The total health sector envelope of TZS 1.8 trillion represents approximately 2.9% of the total national budget. Of the TZS 1.8 trillion, 64% — TZS 1.148 trillion (USD 437.3 million) — is directed to development and 36% — TZS 652.2 billion (USD 248.5 million) — to recurrent expenditure. Of that recurrent portion, TZS 516.3 billion (USD 196.7 million) covers salaries alone, leaving just TZS 135.9 billion (USD 51.8 million) for all non-salary operational spending including the drugs, laboratory reagents, medical supplies, and facility running costs for a system serving over 60 million people.

Within the development envelope, TZS 789.5 billion (USD 300.8 million) is domestically financed and TZS 358.6 billion (USD 136.6 million) comes from external sources. The largest single development commitment is the new Muhimbili National Hospital at TZS 1.2 trillion (USD 457.1 million), financed largely through a concessional loan — a cost-effective investment by international benchmarks, but one that serves a fraction of the population directly and whose debt service obligations will sit within the government’s recurrent budget for decades.

Budget execution compounds the structural picture further. By March 2026, the Ministry of Health had received only 63% of its 2025/26 allocation — 76% of recurrent funds and just 56% of development funds. Capital budgets are consistently the most underfunded in practice. The Ministry also projected own-source revenue collections of TZS 747.2 billion (USD 284.6 million) for 2026/27 from hospitals and institutions — against actual collections of TZS 593.9 billion (USD 226.2 million) by March 2026, equivalent to 72% of the prior year’s annual target. Execution gaps at every level mean that the real operational budget available to the health system is materially smaller than the figures approved by Parliament.

Tanzania also faces intensifying demand for healthcare driven by population growth, urbanisation, and a rapidly shifting disease burden. Expenditure on non-communicable diseases increased by 38% from TZS 1.3 trillion (USD 495.2 million) in 2023 to TZS 1.8 trillion (USD 685.7 million) in 2024, according to the National Health Accounts assessment. NCDs now impose a fiscal burden equivalent to the entire health sector envelope, generating chronic demand that is largely invisible in headline allocation figures focused on infrastructure and communicable disease.

The UHI Sustainability Test

The rollout of Universal Health Insurance remains one of the most consequential reforms in Tanzania’s health sector. Signed into law and operational since January 2026, the UHI scheme seeks to expand financial protection, reduce out-of-pocket spending, and consolidate Tanzania’s fragmented insurance landscape into a unified pooled financing mechanism.

The budget demonstrates continued commitment — TZS 48.8 billion (USD 18.6 million) has been disbursed to reach 172,297 households by March 2026. However, the NHIF data reveals the baseline from which UHI must scale. The Fund covers 1,640,646 members with 6,904,539 beneficiaries — equivalent to just 10.5% of all Tanzanians — having registered 763,793 new members in the period against a target of 1,129,929. Premium revenue is modest, and the scheme’s administrative infrastructure is still being established.

The question facing policymakers is whether Tanzania can create the fiscal and institutional conditions necessary to sustain and scale UHI over the next decade — as coverage expands, utilisation increases, and financing requirements grow — while simultaneously absorbing the donor revenues that currently support disease programmes the UHI architecture has not yet been designed to replace.

The Donor Transition Challenge

One of the most consequential themes in Tanzania’s 2026/27 budget is the intersection between donor transition and health system continuity. For decades, external financing from the Global Fund, GAVI, the World Bank, UNICEF, and bilateral partners has supported programmes covering HIV/AIDS, TB, malaria, immunisation, nutrition, and maternal health — the backbone of primary and preventive care for Tanzania’s most vulnerable populations.

Recent shifts in global health aid have already forced a domestic financing response. The government nearly doubled its domestic health product procurement budget from TZS 200 billion (USD 76.2 million) to TZS 398.2 billion (USD 151.7 million) in 2025/26, with TZS 275 billion (USD 104.8 million) spent by March 2026 — absorbing a portion of what external partners previously financed, particularly antiretroviral drugs. Foreign grants now represent just 0.9% of the total budget.

The scale of the substitution challenge, however, is significant. External development financing within the health sector alone stands at TZS 358.6 billion (USD 136.6 million) in the 2026/27 budget — and this covers only what flows through the Ministry of Health. Global Fund, GAVI, and bilateral programme financing that channels through other mechanisms is additional. If external health financing contracts further across multiple programme areas simultaneously, the domestic budget would need to absorb those gaps consistently and at scale — at a time when the government vote for health has effectively stagnated in real terms. At a tax-to-GDP ratio of 13.7%, that absorption requires either accelerating revenue growth or accepting a managed decline in service quality and coverage. The 2026/27 budget signals awareness of this risk but does not yet contain a financed transition plan that maps the gap between current external support and domestic financing capacity.

Health as an Economic Investment

Tanzania’s health financing decisions are inseparable from its broader economic development trajectory. The government has itself made this connection explicit: the Ministry of Health’s budget speech noted that the quality of health services is a criterion for attracting multinational headquarters and regional offices to Dar es Salaam, and that a modern national hospital reduces medical referrals abroad and supports Tanzania’s ambition to become a hub for regional trade and services. The new Muhimbili National Hospital is framed not merely as a health investment but as economic infrastructure — and at an estimated cost of USD 1,819 per square metre against an international range of USD 3,000 to USD 7,000, the government notes it represents a 42% saving against comparable projects internationally.

That framing should be extended beyond a single flagship project. Tanzania’s HIV programme — which has achieved 95-95-95 targets — keeps a productive working-age population in employment and reduces household economic vulnerability. The planned expansion of 8,000 new community health worker positions in 2026/27 extends health system reach at relatively low cost, keeping the working population healthy at the community level before illness escalates to hospital-level costs. The pharmaceutical manufacturing strategy — with 11 new factories established since 2021, the TPI factory in Arusha revived for ARV production, and the 400-acre Mloganzila Special Economic Zone launched in May 2026 — simultaneously addresses health system supply security and creates domestic industrial capacity, employment, and import substitution benefits that belong in the economic development conversation as much as the health one.

Out-of-pocket health spending remains a structural constraint on household productivity and consumption. Every household facing catastrophic health costs exits the formal economy with reduced productive capacity. UHI, when scaled to meaningful coverage, addresses this constraint directly — and its economic returns extend well beyond the health sector into labour markets, household savings behaviour, and formal sector participation.

Expanding Fiscal Space for Health

While the 2026/27 budget maintains the health sector envelope, sustaining and growing it will depend on Tanzania’s ability to create additional fiscal space over time. Three pathways offer the most tractable near-term opportunities:

• The revenue reform agenda is the largest fiscal lever available. Tax administration transformation — digital platforms, expanded electronic fiscal device coverage, AI-assisted compliance — is projected to generate TZS 1.72 trillion (USD 655.2 million) in additional revenue from proposed amendments alone. Should Tanzania move its tax-to-GDP ratio toward 15% over the next five years, the resulting fiscal dividend would be material. The critical question for health financing advocates is whether the sector is positioned to make a credible claim on that dividend, or whether it defaults to debt service and infrastructure priorities by institutional inertia.
• The pharmaceutical manufacturing strategy creates a meaningful efficiency pathway that is already showing results. MSD currently imports more than 80% of health products from abroad, but priority health product availability at MSD warehouses has already improved from 65% to 71% between December 2025 and March 2026. The Mloganzila SEZ, the TPI ARV factory revival, the Sartorius biopharmaceutical partnership, and the Bio-Equivalent Laboratory under construction collectively represent the most advanced domestic pharmaceutical manufacturing architecture in the region. Every percentage point shift from imported to domestically produced medicines reduces foreign exchange exposure and extends the purchasing power of the existing health allocation.
• Health-earmarked revenue measures: Tanzania introduced an increase in excise duty on cigarettes by TZS 20 per mil, and an increase in the sugar levy by TZS 10 per kilogram on both imported and locally produced sugar, with collections remitted directly to the Universal Health Fund by the Sugar Board of Tanzania. These sin taxes align fiscal incentives with public health goals — taxing products that generate future health costs while channelling proceeds toward the system that manages them. Tanzania already operates ringfenced funds for roads, railways, and rural energy; a statutory floor on health as a share of domestic revenue would build on these levies toward a more comprehensive and predictable domestic health financing framework.

Looking Ahead

Tanzania’s 2026/27 budget demonstrates political commitment to health investment — in UHI, in pharmaceutical manufacturing, in community health workers, and in the domestic absorption of previously donor-financed procurement — at a moment of genuine fiscal constraint. Maternal mortality has fallen from 556 to 104 deaths per 100,000 live births over a decade, the HIV programme has reached 95-95-95, and the facility network has expanded by over 3,500 units since 2021. These achievements reflect sustained commitment and should not be minimised.

The central challenge is that the government vote for health has effectively stagnated in real terms — TZS 406.3 billion (USD 154.8 million) against TZS 405.9 billion (USD 154.6 million) in the prior year — while the NCD burden is growing, donor financing is contracting, and UHI coverage stands at just 10.5% of the population. The UHI ambition, the revenue reform agenda, the pharmaceutical manufacturing strategy, the earmarked levies, and the donor transition risk are each proceeding on separate institutional timelines. The system-level financing gap risks widening between them if they are not brought into a coherent, multi-year domestic health financing strategy.

The success of Tanzania’s health financing agenda will depend on whether UHI expansion, domestic pharmaceutical manufacturing, and revenue reforms can outpace donor withdrawal and rising healthcare demand. Countries with improving growth trajectories and genuine political will for health reform can still find themselves in a structural financing squeeze if the revenue base grows more slowly than development commitments, and if the transition from aid dependence is not managed against a funded domestic financing plan. What Tanzania does in the next three to five budget cycles to build that plan will determine whether the gains of the past decade become the foundation for universal coverage — or the high-water mark of an era of external financing that has passed.

Sources

• United Republic of Tanzania, Ministry of Finance and Planning (2026). Government Budget Speech 2026/2027. Presented to the National Assembly, Dodoma, June 2026. (Original in Swahili; translated by Google Translate)
• United Republic of Tanzania, Ministry of Health (2026). Hotuba ya Waziri wa Afya kwa Mwaka wa Fedha 2026/2027 [Budget Speech of the Minister of Health for the Financial Year 2026/2027]. Presented to the National Assembly, Dodoma, June 2026. (Original in Swahili; translated by Google Translate)